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Background: The purpose of the study was to evaluate time trends and effects of co-existing autism spectrum
disorders (ASD) on outcome in an ongoing long-term follow-up study of anorexia nervosa (AN).
Methods: The Morgan-Russell Outcome Assessment Schedule (MROAS) was used at 6-, 10- and 18-year follow-up
of a representative sample of 51 individuals with teenage-onset AN and a matched group of 51 healthy comparison
cases. The full multinomial distribution of responses for the full scale and each of the subscales was evaluated using
exact nonparametric statistical methods. The impact of diagnostic stability of ASD on outcome in AN was evaluated
in a dose–response model.
Results: There were no deaths in either group. Food intake and menstrual pattern were initially poor in the AN
group but normalised over time. MROAS ‘mental state’ was much poorer in the AN group and did not improve
over time. The psychosexual MROAS domains ‘attitudes’ and ‘aims’ showed persistent problems in the AN group. In
the MROAS socioeconomic domain, the subscales ‘personal contacts’, ‘social activities’ and ‘employment record’ all
showed highly significant between-group differences at all three follow-ups. A statistically significant negative
dose–response relationship was found between a stable diagnosis of ASD over time and the results on the subscales
‘mental state’, ‘psychosexual state’ and ‘socio-economic state’.
Conclusions: Outcome of teenage-onset AN is favourable with respect to mortality and persisting eating disorder,
but serious problems remain in the domains ‘mental state’, ‘psychosexual function’ and ‘socioeconomic state’.
Outcome is considerably worse if ASD is present. Treatment programmes for AN need to be modified so as to
accommodate co-existing ASD.
Keywords: Anorexia nervosa, Autism spectrum disorders, Long-term outcome, Psychosexual, Psychosocial,
Community-based, Prospective, ControlledBackground
Anorexia nervosa (AN) is one of the most serious psy-
chiatric disorders that affect teenagers, predominantly
girls, with an increased risk of a chronic course and pre-
mature death [1-3]. The prevalence of AN is estimated
at 0.3% to 2.2% [3,4]. Long-term outcome in eating dis-
orders (EDs) can be assessed in different areas such as* Correspondence: elisabet.wentz@gnc.gu.se
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unless otherwise stated.mortality, recovery, psychosocial functioning and psychi-
atric and somatic comorbidity. Discouraging data on psy-
chosocial outcome of AN was reported by Ratnasuriya
and co-workers regarding AN patients at 20-year follow-
up [5]. Just over half of the individuals did get married,
and even fewer had children. Further, only half the group
was employed and one third led a very isolated life. Other
follow-up studies confirm that former AN patients marry
less often [6,7]. Twelve percent of Swedish women with a
history of inpatient treatment for AN had a disability pen-
sion at long-term follow-up [8].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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autism spectrum disorder (ASD) and AN came from
Christopher Gillberg more than 30 years ago [9]. Since
then, a substantial body of work has been published, the-
oretical [10-14] as well as clinical and epidemiological
[15-17]. Our group has recently contributed to this body
of evidence [18,19]. In the Gothenburg study, the AN
and the healthy comparison (COMP) groups have so far
been examined on four occasions at mean age 16, 21, 24
and 32 [20-24]. At the time of the latest examination,
18 years had elapsed since the onset of AN. Screening
for ASD has been part of the four examinations of the
AN and COMP groups [18,19]. Thirty-two percent of
the AN group have, at one or more occasions, been
assigned a diagnosis of ASD, and 12% had ASD in all
four waves of the study. The individuals with ASD in the
AN group had the worst psychosocial outcome at 18-
year follow-up [19,25]. The Gothenburg study has also
shown that autistic traits pertaining to social interaction
are overrepresented among the first-degree relatives of
individuals with AN [26].
Earlier work [25,27] prompted us to perform the
present study, with the aim of getting more information
out of the Morgan-Russell outcome assessment schedule
(MROAS) [28,29] than just the average composite score
and general outcome categories, which are convention-
ally the only reported statistics. In particular, we wanted
to analyse the influence of diagnostic stability of ASD on
outcome as measured by these scales.Table 1 Instruments used at AN study 1 to AN study 4 to
assess ASD
Type of instrument
AN study 1 Structured interview with mother
AN study 2 Dewey social awareness test [42], checklist for autistic
disorder [30] and Asperger’s syndrome [43]
AN study 3 Asperger Syndrome Diagnostic Interview [44], checklist
for autistic disorder [31] and Asperger’s syndrome [43]Methods
Participants
Anorexia nervosa group
As a detailed description has been given repeatedly
previously [18-25], it should suffice to describe that the
AN group consisted of 51 cases of teenage-onset AN.
Twenty-three girls and two boys were found via screen-
ing of the whole 1970 birth cohort (N: 4,291) (1 girl re-
fused in-depth study leaving 22 girls and 2 boys for
examination) in Gothenburg, Sweden. This population-
based group was supplemented by another community
sample, 26 girls and 1 boy, who were referred to the re-
search team primarily by school health staff. The latter
group was born mainly in the period 1971 to 1974. All
cases fulfilled DSM-III-R [30] and DSM-IV [31] criteria
for AN within a year of the assessment of the original
study. These two groups combined constituted the AN
group.AN study 4 Asperger Syndrome Diagnostic Interview [44], checklist
for autistic disorder [31] and Asperger’s syndrome [43]
Autism-Spectrum Quotient [45]
AN study 1 first anorexia nervosa examination, AN study 2 second anorexia
nervosa examination, AN study 3 third anorexia nervosa examination, AN study
4 fourth anorexia nervosa examination, ASD autism spectrum disorders.Comparison group
For each of the 51 cases with AN, the school nurses se-
lected the same-sexed classmate without a history of an
ED closest in age to the index child. These individualsserved as healthy controls. Collectively, they were re-
ferred to as the COMP group.
Procedure
At all studies, the AN group and the COMP group were
examined using identical test batteries. All 102 individ-
uals (51 AN and 51 COMP cases) were examined at
baseline, in AN study 1, at age 16, again in AN study 2,
at age 21 (the 6-year follow-up), and in AN study 3, at
age 24 (the 10-year follow-up). In AN study 4, 45 out of
51 in the AN group were examined in person; five were
interviewed over the telephone; and in one case, the
mother was interviewed as she did not want to let the re-
search team have access to her daughter. In the COMP
group, all 51 were interviewed, 48 in person, and three
over the telephone.
At all four examinations, an investigator blinded to the
original AN/COMP group status assigned ASD diagno-
ses. At the time of AN study 1, all mothers took part in
an in-depth interview regarding early development and
childhood symptoms and behaviours. On the basis of
de-identified case notes concerning premorbid history,
the blinded investigator assigned diagnoses of ASD [32].
In each follow-up study [19,25], when only three individ-
uals had persisting underweight, a new blinded investi-
gator assigned ASD diagnoses after personal interview
(see Table 1). Those individuals who had never been
assigned an ASD diagnosis were classified as ‘never ASD’
(n = 34); those who had been assigned an ASD diagnosis in
at least one study but not at all four studies were classified
as ‘ASD× 1-3’ (n = 10), and those with an ASD diagnosis at
all four examinations were classified as ‘ASD× 4’ (n = 6).
One woman in the AN group was not assigned an ASD
category; she was first diagnosed with ASD after suffering
severe traumatic brain injury at about 20 years of age.
Instruments
The Morgan-Russell outcome assessment schedule
(MROAS) [28] is a widely used and well-validated in-
strument, originally designed to enhance good clinical
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facilitate comparisons between treatment centres. The
revision suggested by Morgan and Hayward [29] was used
in this study. Overall outcome was reported after each
follow-up of the Gothenburg study [21,22,25] as Morgan-
Russell’s average composite score and as general outcome
classification (good, intermediate and poor outcome).
In this particular project, we focus on the responses
from each individual on each Morgan-Russell scale and
subscale [28,29].
Ethics
The study was approved by the human ethics committee
at the Medical Faculty of University of Gothenburg. The
individuals participated voluntarily after informed con-
sent was obtained.
Data structure
The responses on the Morgan-Russell scales and sub-
scales range from 0 to 12. The individual scales and
subscales have three, four or five response categories
making the resulting multinomial tables unbalanced with
empty cells. In consequence, statistical methods based
on normality assumptions cannot be used; and instead,
we used exact nonparametric (permutation) statistical
methods [33-36]. Computations were performed in the
program package StatXact8 [37] on a PC platform.
Statistical analysis
This study is a longitudinal study. The overall design is a
repeated measures analysis. The data structure rules out
the use of standard methods like one-way repeated mea-
sures analysis of variance.
The set of multinomial tables was analysed using exact
nonparametric (permutation) methods. Computationally,
these analyses are rather demanding; so in most cases, itTable 2 Morgan-Russell subscale C (mental state); comparison
follow-up
Follow-up AN group COMP g
Response category Respons
0 4 8 12 0 4
6 year 1 10 13 27 0 0
10 year 1 10 14 26 1 2
18 year 2 10 14 25 1 0
Doubly ordered r × c contingency tables Linear-by-linear
association test
Linear-by
associati
Analysis for time trend
Test statistic −0.4583 −0.3885
Exact Monte Carlo P 0.69 0.77
99% CI 0.67 to 0.7 0.76 to 0
AN anorexia nervosa, COMP comparison, CI confidence interval, r × c rows and columis not possible to compute an exact P value due to limi-
tations in RAM memory. Consequently, a Monte Carlo
option is used. Routinely, the sampling procedure is set
to sampling 10,000 tables, which provides an unbiased
point estimate and a 99% confidence interval for the true
P value.
First, we performed analyses of ‘stratified singly or-
dered row by column (r × c) contingency tables’. There
are three strata, one for each follow-up: AN study 2, 3
and 4. There are two groups: AN and COMP. The
analysis is a generalised Cochran-Mantel-Haenszel Test
[35]. The H0 is no association between the r rows (AN
and COMP) and the c columns (response categories) in
any of the s strata (AN study 2, 3 and 4).
Second, we analysed for group differences at each
point in time. The tables are ‘singly ordered r × c contin-
gency tables’ (the rows (AN or COMP) are unordered,
but the columns - the response categories - are ordered),
and thus the relevant test is Kruskal-Wallis Test [33]. H0
the multinomial probabilities across the response cat-
egories are identical in the two groups. Results of the
statistical analyses can be found in the right side of the
raw data in Tables 2, 3 and 4.
Third is the analysis for change over time. Each group
is analysed separately. Data is organised as ‘doubly or-
dered r × c contingency tables’, so the relevant statistical
test is linear-by-linear association test [34]. The rows
correspond to the different follow-ups, and the columns
are the responses. The H0 is the identical multinomial
probabilities at the three points in time, that is, at
AN study 2, 3 and 4. The chosen statistical test is appro-
priate for detecting departures from the null hypothesis
H0 of the form H1 or H′1 or for detecting the two-sided
alternative that either H1 or H′1 is true. Hypothesis H1
implies that as we move from one row to the next, the
probability of the response falling in the next highers between AN and COMP group at 6-, 10- and 18-year
roup Singly ordered r × c contingency
tables Kruskal-Wallis test
Exact Monte Carlo
e category Test statistic P(99% CI)
8 12
8 43 13.72 0.0001 (0 to 0.0004)
4 44 13.91 0 (0 to 0.0005)
7 43 15.43 0.0001 (0 to 0.0005)
-linear
on test
Stratified r × c contingency tables
Cochran-Mantel-Haenszel test
39.72
0
.78 0 to 0.0005
ns.
Table 3 Morgan-Russell subscale E2 (emancipation from family);comparisons between AN and COMP group at 6-, 10-
and 18-year follow-up
Follow-up AN group COMP group Singly ordered r × c contingency
tables Kruskal-Wallis test
Exact Monte Carlo
Response category Response category Test statistic P(99% CI)
0 4 8 12 0 4 8 12
6 year 3 9 9 30 0 2 11 38 4.492 0.032 (0.027 to 0.036)
10 year 2 5 9 35 0 1 12 38 0.948 0.34 (0.33 to 0.35)
18 year 2 3 9 37 0 0 4 47 7.158 0.007 (0.005 to 0.009)
Analysis for time trend doubly
ordered r × c contingency tables
Linear-by-linear
association test
Linear-by-linear association
test
Stratified r × c contingency tables
Cochran-Mantel-Haenszel test
Test statistic +1.715 +2.378 15.8
Exact Monte Carlo P 0.097 0.022 0
99% CI 0.09 to 0.104 0.018 to 0.025 0 to 0.0005
AN anorexia nervosa, COMP comparison, CI confidence interval, r × c rows and columns.
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large positive value of the test statistic rejects H0 in
favour of H1 (that is, a ‘better’ outcome), while a large
negative value rejects H0 in favour of H′1 (that is, a
‘worse’ outcome). The results from this statistical test
are located below each group at the bottom of the
group-difference tables, that is Tables 2, 3 and 4, and at
the right side of the dose–response tables, that is
Tables 5, 6 and 7.
Fourth, we analysed data of the AN group in a dose–
response model in relation to ASD. ‘Dose’ stands for
diagnoses, ordered hierarchically into three groups: never
ASD, ASD × 1–3, ASD × 4. ‘Response’ is the distribution
across the existing response categories. Before any ana-
lyses were undertaken, the principal investigators hypothe-
sised that mental, psychosexual and socioeconomic state
were likely to be influenced by ASD diagnostic stability;
and therefore, data was organised in ‘doubly ordered r × c
contingency tables’, and consequently the relevant test was
a ‘linear-by-linear association test’ [34]. The COMP groupTable 4 Morgan Russell subscale E5 (employment record); com
18-year follow-up
Follow-up AN group COMP group
Response category Response ca
0 4 8 12 0 4 8
6 year 9 4 5 33 4 3 3
10 year 8 3 7 33 1 2 3
18 year 17 3 7 24 2 2 1
Doubly ordered r × c contingency
tables Analysis for time trend
Linear-by-linear
association test
Linear-by-line
association te
Test statistic −1.911 0
Exact Monte Carlo P 0.06 1
99% CI 0.05 to 0.07 0.9995 to 1
AN anorexia nervosa, COMP comparison, CI confidence interval, r × c rows and columwas omitted from these analyses. The results of the statis-
tical tests are located below each study at the bottom of
Tables 5, 6 and 7.
All tests were two tailed and conducted at a 5% signifi-
cance level.
Results
There was no mortality in any group at any follow-up.
Any eating disorder, including AN, bulimia nervosa and
eating disorder not otherwise specified, occurred in 14,
13 and 6 of the individuals in the AN group at AN study
2, 3 and 4, respectively.
AN group versus COMP group
Generally, the findings from the stratified analysis justified
the detailed statistical analyses presented here. The gener-
alised Cochran-Mantel-Haenszel test statistic ranged from
8.7 to 48.2, which translates into exact Monte Carlo P
values in the range 0.003 to <0.001. There were three ex-
ceptions from this general pattern: ‘attitude towardsparisons between AN and COMP group at 6-, 10- and
Singly ordered r × c contingency
tables Kruskal-Wallis test
Exact Monte Carlo
tegory Test statistic P(99% CI)
12
41 3.256 0.077 (0.07 to 0.084)
45 8.245 0.0026 (0.001 to 0.004)
1 36 9.881 0.001 (0.0002 to 0.002)
ar
st
Stratified r × c contingency tables
Cochran-Mantel-Haenszel test
22.8
0
0 to 0.0005
ns.
Table 5 Morgan-Russell subscale C (mental state); dose–response analysis
Dose AN study 2 AN study 3 AN study 4 Analysis for time trend doubly
ordered r × c contingency tables
Linear-by-linear association test
Exact Monte
Carlo
Response category Response category Response category Test Statistic P(99% CI)
0 4 8 12 0 4 8 12 0 4 8 12
Never ASD 0 4 12 18 0 5 9 20 0 6 8 20 0 1 (0.9995 to 1)
ASD × 1-3 0 3 1 6 0 1 4 5 0 2 3 5 0 1 (0.9995 to 1)
ASD × 4 1 3 0 2 1 3 1 1 2 1 3 0 −0.561 0.69 (0.67 to 0.7)
Dose–response analysis
Doubly ordered r × c
contingency tables
Linear-by-linear
association test
Linear-by-linear
association test
Linear-by-linear
association test
Stratified r × c contingency tables
Cochran-Mantel-Haenszel test
Test statistic −1.452 −2.56 −2.787 −4.342
Exact Monte Carlo P 0.15 0.008 0.007 0.0001
99% CI 0.14 to 0.16 0.005 to 0.01 0.005 to 0.009 0 to 0.0004
AN anorexia nervosa, AN study 2 second anorexia nervosa examination, AN study 3 third anorexia nervosa examination, AN study 4 fourth anorexia nervosa
examination, ASD autism spectrum disorders, never ASD individuals who had never been assigned an ASD diagnosis, ASD × 1–3 those who had been assigned an
ASD diagnosis in at least one study, but not at all four studies, ASD × 4 those with an ASD diagnosis at all four examinations, CI confidence interval, r × c rows
and columns.
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sumed their menstruations, so there was not enough data
to compute meaningful and stable figures; the scales ‘atti-
tude to menses (if returned)’ and ‘relationship with nuclear
family’ had P values of 0.09.
Food intake
Scale A1 - dietary restriction
The distribution across categories for the variable ‘Diet-
ary restriction’ showed inter-group difference at the first
and second follow-up (AN study 2: P < 0.0001; AN study
3: P = 0.0003), and no difference at AN study 4. The
change over time was due to improvement in the AN
group. The dose–response analysis, that is, presence of
ASD, showed that the positive development was limitedTable 6 Morgan-Russell subscale E2 (emancipation from fami
Dose AN study 2 AN study 3 AN st
Response category Response category Respo
0 4 8 12 0 4 8 12 0
Never ASD 2 5 8 19 2 2 7 23 0
ASD × 1-3 0 2 0 8 0 1 1 8 0
ASD × 4 1 2 0 3 0 2 1 3 2
Dose–response analysis
doubly ordered r × c
contingency tables
Linear-by-linear
association test
Linear-by-linear
association test
Linea
assoc
Test statistic −0.541 −0.483 −3.81
Exact Monte Carlo P 0.6 0.72 0.000
99% CI 0.59 to 0.62 0.71 to 0.74 0 to 0
AN anorexia nervosa, AN study 2 second anorexia nervosa examination, AN study 3 third
ASD autism spectrum disorders, never ASD individuals who had never been assigned a
least one study, but not at all four studies, ASD × 4 those with an ASD diagnosis at all fto the never ASD group (significant positive trend P =
0.0005. Dose–response relationship was not significant
at any follow-up).
Scale A2 - worry about body weight or appearance
The distribution across categories for the variable ‘Worry
about body weight or appearance’ showed inter-group dif-
ferences at all follow-ups (AN study 2: P < 0.0001; AN
study 3: P < 0.0001; AN study 4: P = 0.018). There was no
relationship between the presence of ASD and scale A2 at
any follow-up.
Scale A3 - body weight
The difference between the AN and the COMP group
was most pronounced at AN study 2 (P < 0.0001), stillly); dose–response analysis
udy 4 Analysis for time trend doubly
ordered r × c contingency tables
Linear-by-linear association test
Exact Monte Carlo
nse category Test statistic P(99% CI)
4 8 12
1 5 28 +2.562 0.01 (0.008 to 0.014)
1 2 7 0 1 (0.9995 to 1)
1 2 1 −0.743 0.54 (0.53 to 0.56)
r-by-linear
iation test
Stratified r × c contingency tables
Cochran-Mantel-Haenszel test
4 −2.606
5 0.01
.001 0.008 to 0.013
anorexia nervosa examination, AN study 4 fourth anorexia nervosa examination,
n ASD diagnosis, ASD × 1–3 those who had been assigned an ASD diagnosis in at
our examinations, CI confidence interval, r × c rows and columns.
Table 7 Morgan-Russell subscale E5 (employment record); dose–response analysis
Dose AN study 2 AN study 3 AN study 4 Analysis for time trend doubly
ordered r × c contingency tables
Linear-by-linear association test
Exact Monte Carlo
Response category Response category Response category Test statistic P(99% CI)
0 4 8 12 0 4 8 12 0 4 8 12
Never ASD 3 3 4 24 4 1 2 27 7 2 6 19 −1.339 0.2 (0.19 to 0.21)
ASD × 1-3 3 1 0 6 0 1 4 5 5 1 0 4 −1.027 0.34 (0.33 to 0.36)
ASD × 4 3 0 0 3 4 1 0 1 4 0 1 1 −0.84 0.48 (0.46 to 0.49)
Dose–response
analysis doubly
ordered r × c tables
Linear-by-linear
association test
Linear-by-linear
association test
Linear-by-linear
association test
Stratified r × c contingency tables
Cochran-Mantel-Haenszel test
Test statistic −2 −3.22 −2.437 −4.385
Exact Monte Carlo P 0.048 0.002 0.013 0
99% CI 0.043 to 0.054 0.0008 to 0.003 0.01 to 0.016 0 to 0.0005
AN anorexia nervosa, AN study 2 second anorexia nervosa examination, AN study 3 third anorexia nervosa examination, AN study 4 fourth anorexia nervosa examination,
ASD autism spectrum disorders, never ASD individuals who had never been assigned an ASD diagnosis, ASD × 1–3 those who had been assigned an ASD diagnosis in at
least one study, but not at all four studies, ASD × 4 those with an ASD diagnosis at all four examinations, CI confidence interval, r × c rows and columns.
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existent at AN study 4 (P = 0.85). This development was
the net result of a significant improvement in the AN
group and an even more significant negative trend in the
COMP group. The dose–response analysis showed that
the positive development in body weight was limited to
the never ASD group, (P = 0.04). There was no indica-
tion of a dose–response effect of ASD on body weight at
any follow-up.
Menstrual pattern - scale B
The largest between-group difference was found at AN
study 2 (P = 0.004), a smaller difference at AN study 3
(P = 0.03), and no difference at AN study 4. This change
over time was mainly due to a significant improvement in
the AN group, and it was diminished by a similar, but not
significant, tendency in the COMP group. The dose–
response analysis showed that the positive trend in the AN
group was limited to the never ASD group (P = 0.0003).
Mental state - scale C
There was a highly significant between-group difference
at all three follow-ups, with a dominance in the AN
group giving responses in the lower categories. There
was a lack of change over time (see Table 2). At AN
study 3 (P = 0.008) and 4 (P = 0.007), a statistically sig-
nificant, negative dose–response relationship was docu-
mented; that is, the more times ASD was present, the
lower the MR scores (see Table 5).
Psychosexual state
Scale D1 - attitude towards sexual matters
The responses for subscale D1 showed significant
between-group differences (AN study 2: P = 0.005; AN
study 3: P = 0.015; AN study 4: P = 0.02). A statisticallysignificant negative dose–response relationship was evi-
dent at AN study 2 (P = 0.02) and 4 (P = 0.0004); that is,
the more often ASD was assigned, the more negative
attitude towards sexual matters.Scale D2 - professed aims in sexual relationships
The findings for the subscale D2 showed no significant
between-group differences at the three follow-ups. Dose–
response analysis did not reach the level of significance at
any of the three follow-ups.Scale D3 - overt sexual behaviour
The distribution across the response categories for sub-
scale D3 indicated significant between-group differences
at all three follow-ups (AN study 2: P = 0.0007; AN study 3:
P = 0.037; AN study 4: P = 0.05). The group ‘never ASD’
showed a statistically significant positive trend (P = 0.003).
A statistically significant negative dose–response relation-
ship was evident at AN study 2 (P = 0.013) and 4 (P =
0.0001).Scale D4 - attitude to menstruation - if it has returned
The responses in subscale D4 did not indicate significant
between-group differences at any point in time, and the
development in the two groups over time was almost
identical; no significant trend in either group. Dose–
response analysis showed no significant difference at
any follow-up.Scale D5 - attitude to menstruation - if it has not returned
Due to few responses (AN study 2: n = 7; AN study 3:
n = 7; AN study 4: n = 5), no differences were detected.
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Scale E1 - relationship with nuclear family
The responses for subscale E1 indicated strained rela-
tionships in the AN group at the first two follow-ups.
There was no difference between groups at AN study 4.
There was no indication of a significant dose–response
relationship at any follow-up.
Scale E2 - emancipation from family
The stratified analysis suggested a large difference be-
tween groups in at least one stratum. The Kruskal-
Wallis test for between-group differences was significant
at AN study 2 (P = 0.032), not significant at AN study 3
(P = 0.34), and highly significant at AN study 4 (P =
0.007) (see Table 3). The detailed analysis indicated a
split in the AN-subgroups - there was a significant posi-
tive trend in the group never ASD (P = 0.01) but not in
the two AN subgroups ASD × 1–3 and ASD × 4, re-
spectively. A highly significant negative dose–response
relationship was evident at AN study 4 (P = 0.0005) -
the more often ASD was assigned, the less emancipation
from family (see Table 3 and 6).
Scale E3 - personal contacts
In subscale E3, there were highly significant between-
group differences at all follow-ups (AN study 2: P =
0.0007; AN study 3: P < 0.0001; AN study 4: P = 0.0001).
The detailed dose–response analysis showed a significant
negative relationship at all three follow-ups (AN study 2:
P = 0.0004; AN study 3: P = 0.0045; AN study 4: P =
0.0003).
Scale E4 - social activities
This dimension of a person’s social life was severely
impaired in the AN group at all follow-ups compared
with the COMP group (AN study 2: P < 0.0001; AN
study 3: P < 0.0001; AN study 4: P = 0.0015). The de-
tailed dose–response analysis showed a significant
negative dose–response relationship at all three follow-
ups (AN study 2: P = 0.013; AN study 3: P = 0.005; AN
study 4: P = 0.005).
Scale E5 - employment record
The employment record, as indicated in subscale E5,
seemed to get progressively worse in the AN group. At
AN study 2, the between-group difference was ap-
proaching the level of statistical significance; and at the
next two follow-ups, the differences were clearly signifi-
cant (see Table 4). The detailed dose–response analysis
showed a marginally significant negative dose–response
relationship at AN study 2 and a clearly significant nega-
tive dose–response relationship at AN study 3 and 4 (see
Table 7).Self-progress rating
Scale G - self-progress rating
Neither time trends nor dose–response relationships
were statistically significant.
Discussion
The present study looks at the Morgan-Russell outcome
data using a different approach compared to our previ-
ous studies [18-22,25]. Here, we analysed the full multi-
nomial distribution across response categories, for all
scales and subscales, at each follow-up, using exact non-
parametric statistical methods [33-36]. We included ana-
lysis of a possible dose–response relationship between
the presence of ASD and outcome in the AN group [34].
The major findings were 1) a clear improvement over
time of the core anorectic symptoms, that is, food in-
take, body weight and menstrual pattern according to
the MROAS in the AN group; 2) ‘Mental state’ and the
psychosexual domains showed lasting problems over
time in the AN group; 3) in the socioeconomic domain,
the subscales ‘personal contacts’, ‘social activities’ and
‘employment record’ all showed highly significant between-
group differences at all three follow-ups; 4) the presence of
ASD, especially when present at all examinations, contrib-
uted to restricted outcomes in the areas mental, psychosex-
ual and socio-economic state.
There was a distinct improvement over time of the an-
orectic symptoms, that is, food intake, body weight and
menstrual pattern according to the MROAS in the AN
group. The improvement was mainly limited to the sub-
group never ASD, which constituted the majority of AN
cases, corresponding to two thirds of the individuals in
the AN group. Mental, psychosexual and socioeconomic
state showed no improvement over time. Even though
only a small minority still had an ED at follow-up, men-
tal state showed poor results due to other psychiatric
disorders in adult years, including affective disorders,
ASD and anxiety disorders and obsessive-compulsive
disorder in particular [22,25]. Similar psychiatric mor-
bidity has also been reported in other long-term follow-
up studies, where alcohol and substance abuse also were
prevalent [6,38]. ASD, on the other hand, has only been
investigated and diagnosed in follow-up studies by our
group.
We have already in previous publications shown that
autistic traits and ASD were overrepresented in this
sample before AN onset and after recovery. Further-
more, we have shown that in the AN group, obsessive-
compulsive personality traits and/or a diagnosis of ASD
are predictors for a worse outcome pertaining to global
assessment of functioning (GAF) [31] and Morgan-
Russell average scale score [25]. This paper presents the
dose–response relationship between presence of ASD
and outcome according to the Morgan-Russell outcome
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ASD; the more diagnostic stability of ASD, the worse the
outcome. Earlier, ASD research has reported autistic
traits dimensionally distributed in the general population
[39], and that these traits have dimensional impact on
overall functioning. The genetic vulnerability in AN is
estimated to be at least 0.50 [40], where one subgroup
consisting of 15% to 20% of AN individuals has a predis-
position in terms of childhood onset autistic traits. The
autistic phenotype makes these individuals more vulner-
able for other psychiatric disorders, including EDs. In
turn, ED or semi-starvation symptoms can also aggra-
vate the autistic traits and lead to social isolation. The
negative organic impact of the brain due to starvation
may worsen the load of autism [41]. We suspect that
this is the case in some of the individuals in our sample;
exhibiting autistic traits in childhood and ending up with
a full ASD syndrome after recovery when the core symp-
toms of the ED have subsided.
The degree of emancipation from family of origin was
less than satisfactory in the AN group at AN study 4,
18 years after onset of AN, at age 32. The difficulties
pertaining to emancipation from family has previously
been elucidated by Ratnasuriya et al. [5] and Löwe et al.
[6]. Our results indicate, however, that the problems
with emancipation from family only occur among those
who have been assigned ASD diagnoses at one or more
occasions.
The findings regarding the employment record area
require special attention. The largest differences between
the AN and the COMP group were seen at AN study 3
and 4, when the individuals were on average 24 and
32 years old, respectively. The phenomenon probably re-
veals how typically developing individuals, such as in the
COMP group, manage to work or study full time in this
period of life, while a significant minority of the AN
group is not able to adapt to adult life after quitting
school. We have previously shown that at mean age 32,
one in four has no paid employment due to a psychiatric
disability [25]. Even though few individuals have a per-
sisting ED 18 years after AN onset, there are still mental
problems, including ASD, that result in poor employ-
ment records.
Strengths
Our study population was community based (as opposed
to a clinical population) and was matched, and data was
collected in a uniform and systematic way both in the
AN and the COMP group. The design was longitudinal
and prospective with several follow-ups. ASD was
ascertained using validated instruments, using re-
searchers blinded to group status. Attrition was zero.
The Morgan-Russell outcome assessment schedule is a
well-validated and widely used instrument. Age andperiod effects could be studied effectively. Effects of ASD
on outcome were studied in detail in a dose–response
model. The statistical models and computations were
compatible with the existing data structure.
Limitations
The narrow age range - most cases were born between
1970 and 1974 - limited the possibility to study cohort
effects. The study took place in one Swedish city -
Gothenburg - which may limit the generalisation of
findings. The relatively small cohort gave limited power
to study the effect of the different predictors.
Clinical implications
Screening for ASD symptomatology with childhood on-
set should be part of the initial assessment of AN pa-
tients. Treatment programmes should be modified to
take account of the special needs of AN patients with
ASD. This point is in agreement with conclusions by
Huke et al. [17].
Research implications
Our findings need replication, in particular by other re-
search teams with access to population-based controlled
samples would be of special interest. In this way, it
might be possible to outline the ‘typical’ response of
each scale or subscale at different ages in the healthy
comparison cases. Possible effects of treatment may also
be teased out.
Conclusions
Outcome of teenage-onset AN is favourable with respect
to mortality and persisting eating disorder, but serious
problems remain in the domains ‘mental state’, ‘psycho-
sexual function’ and ‘socioeconomic state’. Outcome is
considerably worse if ASD is present. Screening for ASD
should be considered in AN patients with treatment
failure.
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